Grove Bank & Trust’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88.6K Hold
373
0.01% 362
2026
Q1
$78.8K Hold
373
0.01% 369
2025
Q4
$76.7K Hold
373
0.01% 368
2025
Q3
$58.5K Hold
373
0.01% 396
2025
Q2
$62.7K Hold
373
0.01% 399
2025
Q1
$51.4K Hold
373
0.01% 408
2024
Q4
$44.1K Buy
373
+60
+19% +$7K 0.01% 380
2024
Q3
$34.6K Buy
313
+57
+22% +$5.96K 0.01% 393
2024
Q2
$25.2K Hold
256
﹤0.01% 413
2024
Q1
$28.6K Hold
256
﹤0.01% 415
2023
Q4
$25.8K Hold
256
﹤0.01% 410
2023
Q3
$22.2K Hold
256
﹤0.01% 447
2023
Q2
$24.2K Sell
256
-16
-6% -$1.35K ﹤0.01% 440
2023
Q1
$20.5K Buy
272
+16
+6% +$1.21K ﹤0.01% 456
2022
Q4
$20K Buy
+256
New +$19.5K ﹤0.01% 456
2017
Q1
Sell
-200
Closed -$14K 547
2016
Q4
$14K Hold
200
0.01% 346
2016
Q3
$16K Sell
200
-60
-23% -$4.85K 0.01% 193
2016
Q2
$20K Buy
260
+60
+30% +$4.78K 0.02% 184
2016
Q1
$16K Hold
200
0.01% 205
2015
Q4
$18K Buy
+200
New +$17K 0.02% 240

Other funds holding CAH

Grove Bank & Trust's CAH Position: Q2 2026 in Review

Grove Bank & Trust held its Cardinal Health (CAH) position steady in Q2 2026 at 373 shares worth $88.6K. The position accounts for 0.01% of the portfolio, ranked #362.

Grove Bank & Trust first reported a position in CAH in Q4 2015 and has held it in 20 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Grove Bank & Trust held 373 shares of Cardinal Health worth $88.6K as of Q2 2026.
  • Grove Bank & Trust left its Cardinal Health share count unchanged in Q2 2026.
  • Cardinal Health made up 0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #362 holding.
  • Grove Bank & Trust first reported a position in Cardinal Health in Q4 2015 and has held it in 20 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.